Dietary quercetin is recovered in rat plasma as conjugated derivatives of isorhamnetin and quercetin

被引:98
作者
Manach, C
Texier, O
Regerat, F
Agullo, G
Demigne, C
Remesy, C
机构
[1] INRA,MALAD METAB LAB,F-63122 ST GENES CHAMPANE,FRANCE
[2] FAC PHARM CLERMONT FERRAND,LAB PHARMACOGNOSIE & BIOTECHNOL,F-63001 CLERMONT FERRAN,FRANCE
关键词
quercetin; rat; metabolism; isorhamnetin; albumin; ESTROGEN-BINDING-SITES; CARCINOGENICITY TEST; CANCER CELLS; FLAVONOIDS; GROWTH; RUTIN; INHIBITION; GENISTEIN;
D O I
10.1016/S0955-2863(96)00058-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Quercetin is present in noticeable amount in human diet and this polyphenolic molecule is supposed to exert beneficial effects on human health. However, its intestinal absorption and its metabolic fate in the organism have not received much attention. In the present study, rats were fed a control or a 0.25% quercetin diet, and the plasma, urine, and bile metabolites of the dietary quercetin were analyzed by HPLC. Conjugated derivatives of quercetin and isorhamnetin, a 3'-O-methylated form of quercetin, were identified in the plasma from the rats fed quercetin. After deconjugation, the concentration of aglycones in the plasma reached 120 +/- 16 mu mol/L, with an isorhamnetin/quercetin ratio of about 5. In bile and in urine, where the 4-oxo-flavonoid concentration were 378 +/- 42 and 128 +/- 19 mu mol/L respectively, conjugated derivatives of quercetin and isorhamnetin, but also of tamarixetin, a 4'-O-methylated form of quercetin were recovered. In plasma, the 4-oxo-flavonoid metabolites are bound to albumin, which induces a bathochromic effect. The bathochromic and chromogenic responses depend on the presence of the unsaturated C2-C3 bound of the C-ring and on the presence of hydroxyl groups on the B-ring. Studies on 4-oxo-flavonoid bioavailability could allow a better understanding of the nutritional effects of various type of plant products.
引用
收藏
页码:375 / 380
页数:6
相关论文
共 38 条
[1]   QUERCETIN EXERTS A PREFERENTIAL CYTOTOXIC EFFECT ON ACTIVE DIVIDING COLON-CARCINOMA HT29 AND CACO-2 CELLS [J].
AGULLO, G ;
GAMET, L ;
BESSON, C ;
DEMIGNE, C ;
REMESY, C .
CANCER LETTERS, 1994, 87 (01) :55-63
[2]  
BOOTH AN, 1956, J BIOL CHEM, V233, P251
[3]  
BORS W, 1990, METHOD ENZYMOL, V186, P343
[4]  
BOUTIN JA, 1993, DRUG METAB DISPOS, V21, P1157
[5]   A REVIEW OF THE GENETIC-EFFECTS OF NATURALLY-OCCURRING FLAVONOIDS, ANTHRAQUINONES AND RELATED-COMPOUNDS [J].
BROWN, JP .
MUTATION RESEARCH, 1980, 75 (03) :243-277
[6]   QUERCETIN AND RUTIN AS INHIBITORS OF AZOXYMETHANOL-INDUCED COLONIC NEOPLASIA [J].
DESCHNER, EE ;
RUPERTO, J ;
WONG, G ;
NEWMARK, HL .
CARCINOGENESIS, 1991, 12 (07) :1193-1196
[7]   FLAVONOIDS INHIBIT THE OXIDATIVE MODIFICATION OF LOW-DENSITY LIPOPROTEINS BY MACROPHAGES [J].
DEWHALLEY, CV ;
RANKIN, SM ;
HOULT, JRS ;
JESSUP, W ;
LEAKE, DS .
BIOCHEMICAL PHARMACOLOGY, 1990, 39 (11) :1743-1750
[8]  
DUMNICK JK, 1992, FUNDAM APPL TOXICOL, V19, P423
[9]   DISPOSITION OF QUERCETIN IN MAN AFTER SINGLE ORAL AND INTRAVENOUS DOSES [J].
GUGLER, R ;
LESCHIK, M ;
DENGLER, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 9 (2-3) :229-234
[10]  
Hackett A.M., 1986, Plant Flavonoids in Biology and Medicine, P177